Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

If you're the parent of a child or teenager, chances are you've heard of social psychologist Jonathan Haidt, or at the very least his wildly influential, bestselling 2024 book, The Anxious Generation.

At a members-only club in Manhattan, a new generation rejects alcohol but isn’t quite ready to give up the party. At the dry New Year’s party at the Maze, a members-only club in Manhattan. At a ...

Nintendo has said it was unwilling to backtrack on the design of Metroid Prime 4: Beyond's controversial open world hub despite seeing "changed" attitudes to open-world games, as the project had ...

PythoC lets you use Python as a C code generator, but with more features and flexibility than Cython provides. Here’s a first look at the new C code generator for Python. Python and C share more than ...

How one era changed everything about the culture — and why we’re so nostalgic for its creations. Gen X How one era changed everything about the culture — and why we’re so nostalgic for its creations.

From analog hobbies to tech curfews, these Gen Zers are experimenting with science-backed ways to help their brains feel a little less foggy. Doomscrolling has taken over our screen time, and ...

FRIDLEY, Minn. — There is a serious buzz Wednesday morning in Fridley - perhaps due to an overload of sugar - as donut giant Krispy Kreme re-enters the Twin Cities market, opening the doors on a new ...

When you do something that no one's done before, you're setting a precedent. You're the blueprint — the start of a new legacy. And if you're setting a precedent as the first person to do or achieve ...

The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...

Monday - Friday, 2:00 - 3:00 PM ET In this article Maze Therapeutics has had a great run since its initial public offering in January — and CEO Jason Coloma is hoping that momentum continues as the ...